Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Fathi

Showing results (81-90 of 168) with videos related to

Pageof 17
Sort By:
Blood Advances|March 19, 2024
A phase 1 study of the irreversible FLT3 inhibitor FF-10101 in relapsed or refractory acute myeloid leukemiaMark Levis, Alexander Perl, Gary Schiller, et al.
The Journal of Molecular Diagnostics : JMD|September 3, 2015
Detection of Dual IDH1 and IDH2 Mutations by Targeted Next-Generation Sequencing in Acute Myeloid Leukemia and Myelodysplastic SyndromesMia Y Platt, Amir T Fathi, Darrell R Borger, et al.
The Oncologist|April 25, 2014
Isocitrate dehydrogenase 1 (IDH1) mutation in breast adenocarcinoma is associated with elevated levels of serum and urine 2-hydroxyglutarateAmir T Fathi, Hossein Sadrzadeh, Amy H Comander, et al.
Cancer|August 30, 2021
Palliative care and coping in patients with acute myeloid leukemia: Mediation analysis of data from a randomized clinical trialAshley M Nelson, Hermioni L Amonoo, Alison R Kavanaugh, et al.
The Lancet. Haematology|June 7, 2016
Potentially avoidable hospital admissions in older patients with acute myeloid leukaemia in the USA: a retrospective analysisAreej El-Jawahri, Tanya Keenan, Gregory A Abel, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 8, 2025
The International Association for the Study of Lung Cancer Staging Project: The Impact of Smoking Status on Lung Cancer Staging in the Ninth Edition of the TNM ClassificationLawson Eng, William K Evans, Megan Eisele, et al.
Leukemia Research|April 18, 2025
A phase I clinical trial of lenalidomide combined with bortezomib for acute myeloid leukemia or myelodysplastic syndrome relapsing after allogeneic stem cell transplantationBrandon J Aubrey, Traci Blonquist, Malgorzata McMasters, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 14, 2022
Relationship Between Longitudinal Coping Strategies and Outcomes in Patients With Acute Myeloid LeukemiaHermioni L Amonoo, Elizabeth Daskalakis, Emma C Deary, et al.
Blood Advances|January 7, 2020
Clinical response to larotrectinib in adult Philadelphia chromosome-like ALL with cryptic ETV6-NTRK3 rearrangementValentina Nardi, Nora Ku, Matthew J Frigault, et al.
Cancer|September 10, 2025
The American Cancer Society National Lung Cancer Roundtable strategic plan: Tobacco treatment in the context of lung cancer screeningJoelle T Fathi, Paul M Cinciripini, Madeline J DePrimo, et al.
Pageof 17

Showing results (81-90 of 168) with videos related to

Sort By:
Pageof 17
Blood Advances|March 19, 2024
A phase 1 study of the irreversible FLT3 inhibitor FF-10101 in relapsed or refractory acute myeloid leukemiaMark Levis, Alexander Perl, Gary Schiller, et al.
The Journal of Molecular Diagnostics : JMD|September 3, 2015
Detection of Dual IDH1 and IDH2 Mutations by Targeted Next-Generation Sequencing in Acute Myeloid Leukemia and Myelodysplastic SyndromesMia Y Platt, Amir T Fathi, Darrell R Borger, et al.
The Oncologist|April 25, 2014
Isocitrate dehydrogenase 1 (IDH1) mutation in breast adenocarcinoma is associated with elevated levels of serum and urine 2-hydroxyglutarateAmir T Fathi, Hossein Sadrzadeh, Amy H Comander, et al.
Cancer|August 30, 2021
Palliative care and coping in patients with acute myeloid leukemia: Mediation analysis of data from a randomized clinical trialAshley M Nelson, Hermioni L Amonoo, Alison R Kavanaugh, et al.
The Lancet. Haematology|June 7, 2016
Potentially avoidable hospital admissions in older patients with acute myeloid leukaemia in the USA: a retrospective analysisAreej El-Jawahri, Tanya Keenan, Gregory A Abel, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 8, 2025
The International Association for the Study of Lung Cancer Staging Project: The Impact of Smoking Status on Lung Cancer Staging in the Ninth Edition of the TNM ClassificationLawson Eng, William K Evans, Megan Eisele, et al.
Leukemia Research|April 18, 2025
A phase I clinical trial of lenalidomide combined with bortezomib for acute myeloid leukemia or myelodysplastic syndrome relapsing after allogeneic stem cell transplantationBrandon J Aubrey, Traci Blonquist, Malgorzata McMasters, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 14, 2022
Relationship Between Longitudinal Coping Strategies and Outcomes in Patients With Acute Myeloid LeukemiaHermioni L Amonoo, Elizabeth Daskalakis, Emma C Deary, et al.
Blood Advances|January 7, 2020
Clinical response to larotrectinib in adult Philadelphia chromosome-like ALL with cryptic ETV6-NTRK3 rearrangementValentina Nardi, Nora Ku, Matthew J Frigault, et al.
Cancer|September 10, 2025
The American Cancer Society National Lung Cancer Roundtable strategic plan: Tobacco treatment in the context of lung cancer screeningJoelle T Fathi, Paul M Cinciripini, Madeline J DePrimo, et al.
Pageof 17